Gene · 8021
NIH grants1,200
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 1,200
Download this page as JSON| Grant | Title | NUP214 papers | Newest fiscal year |
|---|---|---|---|
| P01DK096990 | New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency | 1 | 2023 |
| P20GM103636 | Expanding Excellence in Developmental Biology in Oklahoma Supplement: 3D Human Lung Tissue Model to Dissect Cellular Responses upon SARS-CoV-2 Infection | 1 | 2023 |
| P50CA100707 | SPORE in Multiple Myeloma | 1 | 2023 |
| P50CA127003 | Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer | 1 | 2023 |
| R00HD097286 | Integrative analysis of human placental epi/genome in relation to fetal growth | 1 | 2023 |
| R01CA054358 | Epigenetic drivers of cancer progression | 1 | 2023 |
| R01CA178999 | Mechanisms of SIRT2 Function in the DNA Damage Response | 1 | 2023 |
| R01CA236118 | Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer | 1 | 2023 |
| R01CA236209 | Identification of Druggable Targets to Complement Melanoma Therapy | 1 | 2023 |
| R01CA236949 | Role of SETD5 in Chromatin Regulation and Tumorigenesis | 1 | 2023 |
| R01CA241930 | Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC) | 1 | 2023 |
| R01DE025020 | Mechanisms of Pro-Resolving Mediators in Periodontal Regeneration | 1 | 2023 |
| R01DK052913 | Epigenomic Regulation in Pancreatic Cell Growth | 1 | 2023 |
| R01DK061972 | Mucosal Repair in Gut Surgical Disorders | 1 | 2023 |
| R01DK094004 | Mechanistic Target of Rapamycin Pathways in Metabolism and Energy Expenditure | 1 | 2023 |
| R01GM087388 | Function of photobodies in Arabidopsis photoreceptor signaling | 1 | 2023 |
| R01GM114141 | Mechanisms mediating immune response upon sensing of nuclear viral DNA | 1 | 2023 |
| R01GM127711 | Capturing Low-Abundance Glycopeptides for Decoding the Glycoproteome | 1 | 2023 |
| R01GM134382 | Intracellular and Intercellular Network Rewiring and Hidden Driver Inference from Single-Cell Data | 1 | 2023 |
| R01HL082792 | Nuclear mechanics and mechanotransduction in muscular laminopathies | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8021/grants?page=18